• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Japan-Based Nidek to Strengthen Opthalmic Business in India

      Posted AtPharmaBiz

      Nidek Co Ltd., a leading Japanese company in the field of ophthalmic equipment, is planning to strengthen its business in India. Presently, NIDEK has a distributor partnership in India with Delhi-based KLB Instruments, the company which is marketing NIDEK's medical equipment and products in the country.

      Motoki Ozawa, vice president of Nidek Co. Ltd told Pharmabiz, "We have sold extensively around India our Phacoemulcification Equipment through our strong distributor partnership with KLB Instruments. We have an outstanding ophthalmic laser and diagnostic platform that we want to now build for growing the IOL (Intraocular Lens) market in India. We believe that Nidek is in a very strong position to leverage further growth and build NIDEK's franchise in the IOL market in India - through product bundling, existing product users and most importantly a strong distribution network in India."

      Nidek Co. Ltd. had received CE Mark approval for its newly introduced Nidek CV-7000 Phacoemulcification System and Nidek's Nex-Acri IOL.

      Nidek is also globally building a strong and established business in the area of retina/ posterior segment with diagnostics instrumentation. This is an area of great focus for Nidek.

      "With our recently launched Nex-Acri IOL, Nidek's hydrophobic acrylic foldable IOL, we look to develop and expand our reach into the growing market segments of cataract surgery and intraocular lenses. Nidek's excellent diagnostic platform, ophthalmic lasers and now cataract / phacoemulcification systems paired with Nidek's IOLs will continue our long-term strategy of growth and market development in Europe, Middle East and Asia," he added.

      The Nidek CV-7000 Phacoemulcification System delivers a new standard in cataract surgery, providing a high-repetitive pulse mode for excellent operability and reduced thermal / heat generation.

      Nidek's prodcts are classified into various sections like-- Refractive Surgery; Imaging & Communication Software; Surgical Lasers & Equipment; Intraocular Lens; Diagnostic Equipment etc.

      Founded in 1971, Nidek is claimed to be the world's leading supplier of surgical and diagnostic products for vision care. Based in Gamagori, Japan, Nidek is today firmly established in over 90 countries through a network of wholly owned subsidiaries and specialist independent distributors.

      Nowadays a number of Japanese pharmaceutical companies are keen on making business relations with Indian companies for joint research, product outsourcing, and marketing alliances. Recently, Eisai Pharmaceuticals India Private Ltd., launched as the Indian subsidiary of the Japanese pharma major, Eisai Co Ltd., had signed agreements with GSK India to market Parit, Eisai's new generation Proton Pump inhibitor for gastric disorders and Wockhardt for the manufacture of its Alzheimers drug Aricept in India. The company is also planning to launch new products in the gastroenterology and CNS segments within one year in India.

      September 20, 2005


      Share this Article!

    Back to top^